The UroGist is a podcast series from UroGen Pharma, that takes an informative and engaging look at the latest in urologic oncology through enlightening and interesting conversations with leading urologists and other stakeholders. Hosted by Dr. Michael Louie, the SVP of Medical Affairs and Clinical Development at UroGen. The UroGist seeks to provide a more contextualized understanding of advances in the field that are reshaping the treatment landscape for urologic cancers.
All content for The UroGist is the property of UroGen® Pharma and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The UroGist is a podcast series from UroGen Pharma, that takes an informative and engaging look at the latest in urologic oncology through enlightening and interesting conversations with leading urologists and other stakeholders. Hosted by Dr. Michael Louie, the SVP of Medical Affairs and Clinical Development at UroGen. The UroGist seeks to provide a more contextualized understanding of advances in the field that are reshaping the treatment landscape for urologic cancers.
The UroGist is a podcast series from UroGen Pharma, that takes an informative and engaging look at the latest in urologic oncology through enlightening and interesting conversations with leading urologists and other stakeholders. Hosted by Dr. Michael Louie, the SVP of Medical Affairs and Clinical Development at UroGen. The UroGist seeks to provide a more contextualized understanding of advances in the field that are reshaping the treatment landscape for urologic cancers.
